苯丙氨酸羟化酶
高苯丙氨酸血症
突变
生物
苯丙氨酸
苯丙酮尿症
酪氨酸
生殖系
先天性代谢错误
突变
突变体
遗传学
种系突变
点突变
基因
生物化学
氨基酸
作者
Alexandra Shedlovsky,J. David McDonald,Derek J. Symula,William F. Dove
出处
期刊:Genetics
[Oxford University Press]
日期:1993-08-01
卷期号:134 (4): 1205-1210
被引量:236
标识
DOI:10.1093/genetics/134.4.1205
摘要
Abstract Phenylketonuria (PKU) results from a deficiency in phenylalanine hydroxylase, the enzyme catalyzing the conversion of phenylalanine (PHE) to tyrosine. Although this inborn error of metabolism was among the first in humans to be understood biochemically and genetically, little is known of the mechanism(s) involved in the pathology of PKU. We have combined mouse germline mutagenesis with screens for hyperphenylalaninemia to isolate three mutants deficient in phenylalanine hydroxylase (PAH) activity and cross-reactive protein. Two of these have reduced PAH mRNA and display characteristics of untreated human PKU patients. A low PHE diet partially reverses these abnormalities. Our success in using high frequency random germline point mutagenesis to obtain appropriate disease models illustrates how such mutagenesis can complement the emergent power of targeted mutagenesis in the mouse. The mutants now can be used as models in studying both maternal PKU and somatic gene therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI